Table 3.
Comparison of patients with serum uric acid levels above UA ≥7mg/dl in three subgroups.
| UA ≥ 7mg/dl – 7.9 mg/dl (n, %) | UA ≥ 8 mg/dl – 8.9 mg/dl (n, %) | UA ≥ 9 mg/dl (n, %) | P value | ||
|---|---|---|---|---|---|
| Gender | Male | 178 (65.9) | 99 (67.8) | 48 (67.6) | 0,914 |
| Female | 92 (34.1) | 47 (32.2) | 23 (32.4) | ||
| CKD | 174 (64.4) | 114 (78.1) | 54 (76.1) | 0.008 | |
| DM | 147 (54.4) | 69 (47.3) | 33 (46.5) | 0.262 | |
| HL | 112 (41.5) | 61 (41.8) | 38 (53.5) | 0.172 | |
| HT | 169 (62.6) | 86 (58.9) | 48 (67.6) | 0.455 | |
| NL | 15 (5.6) | 4 (2.7) | 10 (14.1) | 0.004 | |
| CVD | 63 (23.3) | 44 (30.1) | 25 (35.2) | 0.083 | |
| Alcohol | 4 (1.5) | 3 (2.1) | 2 (2.8) | 0.740 | |
| Gout | 9 (3.3) | 8 (5.5) | 4 (5.6) | 0.494 | |
| ULDs | Alloprinol | 40 (14.8) | 22 (15.1) | 27 (38) | <0.001 |
| Febuxostate | 0 (0) | 0 (0) | 1 (1.4) | ||
UA: uric acid; CKD: chronic kidney disease; DM: diabetes mellitus; HL: hyperlipidaemia; HT: hypertension; NL: nephrolithiasis; CVD: cardiovascular disease.